The posters that BioIVT presented at this year's ISSX Meeting, "An Evaluation of CYP and Non-CYP Reaction Phenotyping Study Trends from 2000-2023" and "Monocarboxylate Transporters 8 and 10: Siblings with Different Personalities," are now available to download. View Posters
Learn about the tiered options that BioIVT offers for many drug-drug interaction and drug metabolism studies, including the differences between the tiers and which would be most appropriate for your specific goals and stage of development. Read More
This article provides an industry overview from the perspective of drug safety, including a discussion of approved ADCs as well as drug interaction guidance, cases and strategies for in vitro evaluation. Read More
Proper thawing and plating is critical to ensuring your data is as accurate as possible. Take a look at this instructional video for useful information and tips to maximize the performance of your cells. Watch Now
Researchers have been using BioIVT's HEPATOPAC as a long-term functional in vitro model for compound screening, toxicity evaluation and assessment of gene regulation. View Research
Dissociated tumor cells (DTCs) offer significant advantages in in vitro drug screening and evaluation, personalized medicine applications, and modeling tumor heterogeneity. However, ethical considerations in sourcing starting materials and the limitations of DTCs must be carefully managed. View Research
Want to reach 137,000+ Fierce Biotech subscribers with your own message? Contact aalcover@questex.com or call 202-824-5074.
You are currently subscribed as newsletter@newslettercollector.com. If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe. Refer to our Privacy Policy.
Questex, LLC 685 3rd Avenue, 21st Floor New York, NY 10017
